Ligand Pharmaceuticals Inc. (LGND)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

40

0

4

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Mar-24 10:00 PM View:	05-Mar-24 Option Exercise $113.84K	Aryeh Jason Director		Ligand Pharmaceuticals Inc. - LGND	2% 128.15K to 131.04K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 1:27 PM View:	05-Mar-24 Option Sale ($140.65K)	Sabba Stephen L Director		Ligand Pharmaceuticals Inc. - LGND	4% 27.93K to 28.93K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 6:50 PM View:	28-Feb-24 Option Sale ($12.38K)	Espinoza Octavio Chief Financial Officer		Ligand Pharmaceuticals Inc. - LGND	30% 22.9K to 29.75K	0	0	--	--	Show Txns Hide Txns

27-Mar-24 5:47 PM View:	25-Mar-24 Option Exercise $919.15K	Davis Todd C Chief Executive Officer Director		Ligand Pharmaceuticals Inc. - LGND	64% 73.09K to 120.16K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 6:50 PM View:	27-Feb-24 Grant 0	Korenberg Matthew E PRESIDENT & CHIEF OPERATING		Ligand Pharmaceuticals Inc. - LGND	10% 94.22K to 103.86K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 6:50 PM View:	27-Feb-24 Grant 0	Reardon Andrew CHIEF LEGAL OFFICER &		Ligand Pharmaceuticals Inc. - LGND	42% 15.59K to 22.2K	0	0	--	--	Show Txns Hide Txns